Logo
I

Immuneed

28 employees

Immuneed is developing a new generation of prostate cancer vaccines, based on activation of the body's own immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Immuno-oncology
Cytokine Release Assay
Safety Assessment
Peptides
Contract research organization
Monoclonal antibodies
Proteins
Immunotoxicity
Small molecules
Drug development
Virus
MoA
In-Vitro Immunotoxicity
ADCC & CDC assays
Platelet activation
Immune profiling
Monocyte activation
Biologics
Health Care
non-clinical
Innate Immunity
Complement Activation
Functional studies
Immune complexes

Date founded

2014

Funding rounds raised

Total raised

$507K

from 1 investors over 1 rounds

I

Immuneed raised $507K on September 13, 2016

Investors: Almi Invest

FAQ